JP2007527902A5 - - Google Patents

Download PDF

Info

Publication number
JP2007527902A5
JP2007527902A5 JP2007502348A JP2007502348A JP2007527902A5 JP 2007527902 A5 JP2007527902 A5 JP 2007527902A5 JP 2007502348 A JP2007502348 A JP 2007502348A JP 2007502348 A JP2007502348 A JP 2007502348A JP 2007527902 A5 JP2007527902 A5 JP 2007527902A5
Authority
JP
Japan
Prior art keywords
alkyl
phenyl
hydrogen
group
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007502348A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007527902A (ja
JP4856623B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2005/051086 external-priority patent/WO2005087724A2/en
Publication of JP2007527902A publication Critical patent/JP2007527902A/ja
Publication of JP2007527902A5 publication Critical patent/JP2007527902A5/ja
Application granted granted Critical
Publication of JP4856623B2 publication Critical patent/JP4856623B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2007502348A 2004-03-11 2005-03-10 新規のn−スルホニルピロール誘導体 Expired - Lifetime JP4856623B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04101003 2004-03-11
EP04101003.4 2004-03-11
PCT/EP2005/051086 WO2005087724A2 (en) 2004-03-11 2005-03-10 Sulphonylpyrroles as hdac inhibitors

Publications (3)

Publication Number Publication Date
JP2007527902A JP2007527902A (ja) 2007-10-04
JP2007527902A5 true JP2007527902A5 (OSRAM) 2008-04-10
JP4856623B2 JP4856623B2 (ja) 2012-01-18

Family

ID=34928899

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007502348A Expired - Lifetime JP4856623B2 (ja) 2004-03-11 2005-03-10 新規のn−スルホニルピロール誘導体

Country Status (25)

Country Link
US (5) US7842820B2 (OSRAM)
EP (2) EP1725528B1 (OSRAM)
JP (1) JP4856623B2 (OSRAM)
KR (1) KR101130556B1 (OSRAM)
CN (1) CN1926103B (OSRAM)
AR (1) AR048427A1 (OSRAM)
AU (1) AU2005221834B2 (OSRAM)
BR (1) BRPI0508464B8 (OSRAM)
CA (1) CA2558552C (OSRAM)
CY (1) CY1114284T1 (OSRAM)
DK (1) DK1725528T3 (OSRAM)
EA (1) EA012451B1 (OSRAM)
ES (1) ES2430371T3 (OSRAM)
HR (1) HRP20130810T1 (OSRAM)
IL (1) IL177168A (OSRAM)
ME (1) ME02122B (OSRAM)
NO (1) NO337457B1 (OSRAM)
NZ (1) NZ549251A (OSRAM)
PL (1) PL1725528T3 (OSRAM)
PT (1) PT1725528E (OSRAM)
RS (1) RS52937B (OSRAM)
SI (1) SI1725528T1 (OSRAM)
TW (1) TWI353977B (OSRAM)
WO (1) WO2005087724A2 (OSRAM)
ZA (1) ZA200606315B (OSRAM)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0412259B1 (pt) 2003-07-22 2019-08-20 Astex Therapeutics Limited Compostos de 1H-pirazol 3,4-dissubstituídos como moduladores de quinases dependentes de ciclina (CDK), seus usos, processo para a preparação dos mesmos e composição farmacêutica
EP1725528B1 (en) * 2004-03-11 2013-05-29 4Sc Ag Sulphonylpyrroles as hdac inhibitors
CA2594477C (en) * 2005-01-21 2016-07-12 Astex Therapeutics Limited Pharmaceutical compounds
US8404718B2 (en) 2005-01-21 2013-03-26 Astex Therapeutics Limited Combinations of pyrazole kinase inhibitors
AR054425A1 (es) 2005-01-21 2007-06-27 Astex Therapeutics Ltd Sales de adicion de piperidin 4-il- amida de acido 4-(2,6-dicloro-benzoilamino) 1h-pirazol-3-carboxilico.
EA201100689A1 (ru) * 2005-03-15 2011-10-31 4Сц Аг N-сульфонилпирролы и их применение в качестве ингибиторов гистондезацетилазы
US20090117074A1 (en) * 2005-04-07 2009-05-07 Nycomed Gmbh Sulfonylpyrroles as Histone Deacetylase Inhibitors
NZ541788A (en) * 2005-08-11 2007-12-21 Auckland Uniservices Ltd Conducting polymers and their use in oligonucleotide (ODN) probes
KR101314158B1 (ko) * 2005-09-21 2013-10-04 4에스체 악티엔게젤샤프트 히스톤 탈아세틸 효소 억제제로서의 설포닐피롤 염산염
PL1928872T3 (pl) 2005-09-21 2012-08-31 4Sc Ag Nowe sulfonylopirole jako inhibitory HDAC
PL1975158T3 (pl) * 2005-12-27 2011-12-30 Univ Del Pais Vasco Euskal Herriko Unibersitatea Nowe pochodne pirolu o aktywności inhibitującej deacylazę histonową
EP2100878A1 (en) * 2008-03-12 2009-09-16 4Sc Ag Novel method for the production of sulphonylpyrroles as HDAC inhibitors
EP2100882A1 (en) * 2008-03-12 2009-09-16 4Sc Ag (E) -N -(2-Amino-phenyl) -3-{1-[4-(1-methyl-1H-pyrazol-4-yl)- benzenesulfonyl]-1H-pyrrol-3-yl} -acrylamide salts
EP2306836B1 (en) * 2008-07-01 2016-09-07 PTC Therapeutics, Inc. Bmi-1 protein expression modulators
CA2735593C (en) 2008-09-03 2017-08-15 Repligen Corporation Compositions including 6-aminohexanoic acid derivatives as hdac inhibitors
CN101941948A (zh) * 2009-07-10 2011-01-12 南开大学 点击化学合成具有分支结构的组蛋白去乙酰酶抑制剂
EP2680694B1 (en) 2011-02-28 2019-01-02 BioMarin Pharmaceutical Inc. Histone deacetylase inhibitors
US8957066B2 (en) 2011-02-28 2015-02-17 Biomarin Pharmaceutical Inc. Histone deacetylase inhibitors
US10059723B2 (en) 2011-02-28 2018-08-28 Biomarin Pharmaceutical Inc. Histone deacetylase inhibitors
MX370142B (es) 2013-03-15 2019-12-03 Biomarin Pharm Inc Inhibidores de hdac.
EP3062783B1 (en) 2013-10-18 2020-08-12 The General Hospital Corporation Imaging histone deacetylases with a radiotracer using positron emission tomography
SG11201608303QA (en) 2014-04-04 2016-11-29 Del Mar Pharmaceuticals Use of dianhydrogalactitol and analogs or derivatives thereof to treat non-small-cell carcinoma of the lung and ovarian cancer
CN105801464B (zh) * 2014-12-29 2019-05-28 成都先导药物开发有限公司 吡咯酰胺类化合物及其制备方法与用途
JP2019511544A (ja) 2016-04-14 2019-04-25 4エスツェー アクチェンゲゼルシャフト アジア人患者におけるレスミノスタットの医薬用途
TW201912183A (zh) 2017-08-31 2019-04-01 德商4Sc製藥公司 Hdac抑制劑與抗代謝藥劑組合用於癌症治療
WO2019200238A1 (en) 2018-04-14 2019-10-17 Dynavax Technologies Corporation Combinations including a cpg-c type oligonucleotide and a histone deacetylase inhibitor for treating cancer
CN112055589A (zh) 2018-04-17 2020-12-08 4Sc股份公司 用于癌症治疗的包含hdac抑制剂、lag-3抑制剂和pd-1抑制剂或pd-l1抑制剂的组合
TW202114659A (zh) 2019-10-02 2021-04-16 德商4Sc製藥公司 用於癌症治療之含hdac抑制劑、ctla—4抑制劑及pd—1抑制劑或pd—l1抑制劑之組合

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4960787A (en) 1989-02-06 1990-10-02 Ciba-Geigy Corporation Certain pyrrolyl-substituted hydroxamic acid derivatives
KR100236806B1 (ko) 1991-12-10 2000-01-15 시오노 요시히코 방향족 설폰아미드계 하이드록삼산 유도체
WO1996038418A1 (en) 1995-06-02 1996-12-05 G.D. Searle & Co. Heterocyclo substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors
KR20070053362A (ko) * 1999-11-23 2007-05-23 메틸진, 인크. 히스톤 디아세틸라제의 억제제
EP1259506A1 (en) 1999-11-23 2002-11-27 Merck & Co., Inc. Pyrazinone thrombin inhibitors
US6521618B2 (en) 2000-03-28 2003-02-18 Wyeth 3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
RU2315746C2 (ru) 2001-08-09 2008-01-27 Оно Фармасьютикал Ко., Лтд. Производные карбоновых кислот и фармацевтическое средство, содержащее их в качестве активного ингредиента
US7868204B2 (en) 2001-09-14 2011-01-11 Methylgene Inc. Inhibitors of histone deacetylase
CN1578663B (zh) 2001-09-14 2011-05-25 梅特希尔基因公司 组蛋白脱乙酰化酶抑制剂
OA12792A (en) * 2002-03-13 2006-07-10 Janssen Pharmaceutica Nv Sulfonyl-derivatives as novel inhibitors of histone deacetylase.
JP2006512306A (ja) 2002-08-29 2006-04-13 テンプル・ユニバーシティ−オブ・ザ・コモンウェルス・システム・オブ・ハイアー・エデュケイション アリール及びヘテロアリールプロペンアミド、それらの誘導体並びにそれらの治療用途
GB0226855D0 (en) 2002-11-18 2002-12-24 Queen Mary & Westfield College Histone deacetylase inhibitors
AU2004268621C1 (en) 2003-08-29 2011-08-18 Exelixis, Inc. c-Kit modulators and methods of use
EP1709007A1 (en) 2004-01-22 2006-10-11 Altana Pharma AG N-4-(6-(heteo)aryl-pyrimidin-4-ylaminophenyl)-benzenesulfonamides as kinase inhibitors
US20050197336A1 (en) 2004-03-08 2005-09-08 Miikana Therapeutics Corporation Inhibitors of histone deacetylase
EP1725528B1 (en) * 2004-03-11 2013-05-29 4Sc Ag Sulphonylpyrroles as hdac inhibitors
US7345043B2 (en) 2004-04-01 2008-03-18 Miikana Therapeutics Inhibitors of histone deacetylase
GB2415703A (en) 2004-07-02 2006-01-04 Hewlett Packard Development Co Liquid crystal display device
UA87884C2 (uk) 2004-12-03 2009-08-25 Мерк Энд Ко., Инк. Безводна кристалічна калієва сіль інгібітора віл-інтегрази
US7432808B2 (en) 2004-12-15 2008-10-07 Intel Corporation Wireless module enabled component carrier for parts inventory and tracking
EP1831173B1 (en) 2004-12-17 2011-01-26 Janssen Pharmaceutica NV Tetrahydroisoquinoline compounds for treatment of cns disorders
EA201100689A1 (ru) 2005-03-15 2011-10-31 4Сц Аг N-сульфонилпирролы и их применение в качестве ингибиторов гистондезацетилазы
US20090117074A1 (en) 2005-04-07 2009-05-07 Nycomed Gmbh Sulfonylpyrroles as Histone Deacetylase Inhibitors
PL1928872T3 (pl) 2005-09-21 2012-08-31 4Sc Ag Nowe sulfonylopirole jako inhibitory HDAC
KR101314158B1 (ko) * 2005-09-21 2013-10-04 4에스체 악티엔게젤샤프트 히스톤 탈아세틸 효소 억제제로서의 설포닐피롤 염산염
EP2060565A1 (en) * 2007-11-16 2009-05-20 4Sc Ag Novel bifunctional compounds which inhibit protein kinases and histone deacetylases
EP2100882A1 (en) * 2008-03-12 2009-09-16 4Sc Ag (E) -N -(2-Amino-phenyl) -3-{1-[4-(1-methyl-1H-pyrazol-4-yl)- benzenesulfonyl]-1H-pyrrol-3-yl} -acrylamide salts

Similar Documents

Publication Publication Date Title
JP2007527902A5 (OSRAM)
Harris et al. Discovery and evaluation of 2-anilino-5-aryloxazoles as a novel class of VEGFR2 kinase inhibitors
Vergani et al. Novel benzohydroxamate-based potent and selective histone deacetylase 6 (HDAC6) inhibitors bearing a pentaheterocyclic scaffold: design, synthesis, and biological evaluation
US8785489B2 (en) Heteroaryl substituted indole compounds useful as MMP-13 inhibitors
JP6531100B2 (ja) キナーゼ阻害剤としての置換ニコチンアミド誘導体
JP6326057B2 (ja) 置換ピリミジニルおよびピリジニル−ピロロピリジノン、これらの調製のための方法、およびキナーゼ阻害剤としてのこれらの使用
JP6017313B2 (ja) 化合物および方法
Peifer et al. Design, synthesis, and biological evaluation of novel 3-aryl-4-(1 H-indole-3yl)-1, 5-dihydro-2 H-pyrrole-2-ones as vascular endothelial growth factor receptor (VEGF-R) inhibitors
JP2012510989A5 (OSRAM)
JP5524173B2 (ja) 抗増殖性化合物およびその治療的使用
JP7175888B2 (ja) 選択的hdac1、2阻害剤としてのピペラジン誘導体
JP2022191395A (ja) 選択的hdac6阻害剤
AU2010289353A1 (en) Compounds as tyrosine kinase modulators
RU2006117635A (ru) Производные индолинона и их применение для лечения патологических состояний, таких как злокачественное новообразование
Spicer et al. Exploration of a series of 5-arylidene-2-thioxoimidazolidin-4-ones as inhibitors of the cytolytic protein perforin
JP2006500348A5 (OSRAM)
RU2009104770A (ru) Производные пиримидина в качестве ингибиторов alk-5
JP2010513304A5 (OSRAM)
CA2453175A1 (en) Interaction inhibitors of tcf-4 with beta-catenin
EA014245B1 (ru) Аналоги арилпропионамида, арилакриламида, арилпропинамида или арилметилмочевины в качестве ингибиторов фактора xia
RU2007117913A (ru) 2, 6-замещенные-4-монозамещенный амино-пиримидины как антагонисты рецептора простагландина d2
Lorthiois et al. Discovery of highly potent and selective small-molecule reversible factor D inhibitors demonstrating alternative complement pathway inhibition in vivo
JP2020520354A5 (OSRAM)
JP2020516671A5 (OSRAM)
JP2011510985A5 (OSRAM)